AzTrials
AzTrials

Intrathecal Pump RefillIMPROVENCT07727798

Intrathecal Pump Refills at Home or at the Hospital

A study testing Refill at the hospital and Refill at home in people with Intrathecal Pump Refill, run by Moens Maarten at 1 site in Belgium.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The IMPROVE study is a randomized, controlled, cross-over trial designed to compare intrathecal pump refills performed at home with those carried out in the hospital. Intrathecal drug delivery (IDD) is used in patients with chronic pain or severe spasticity. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Intrathecal Pump Refill
What is being tested?
Refill at the hospital and Refill at home
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
82 participants
Where
1 siteBelgium
Study dates
15 Oct 2025to 1 Oct 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Actively receiving Intrathecal drug delivery
  • Stable medication dosage for at least 3 months
  • Dutch, French or English speaking adults

Who cannot join

  • Life expectancy < 6 months
  • Patients planned for but not yet received Intrathecal drug delivery implant
  • No residence in Belgium

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Maarten Moens, MD PhD contact

+3224775514

stimulusresearchgroup@gmail.com

Lisa Goudman, PhD contact

+32472412507

lisa.goudman@vub.be

Belgium1 site, 1 recruiting
  • UZ Brussel

    Jette, 1090

    Maarten Moens, MD PhD

    Ulrike Van Hoey, MSc

    Recruiting

Other trials in Belgium

About this study

Official title: Intrathecal Pump Refills at Home or at the Hospital: a Randomized Controlled Crossover Trial

The IMPROVE study is a randomized, controlled, cross-over trial designed to compare intrathecal pump refills performed at home with those carried out in the hospital. Intrathecal drug delivery (IDD) is used in patients with chronic pain or severe spasticity. Use of IDD requires the performance of pump refills about 4-6 times a year which may be a burdensome and stressful experience for patients and their caregivers. Hospital visits can increase stress, pain, and caregiver strain, while early pilot studies suggest home-based refills may be both safe and more comfortable.

Eighty-two adult patients in Belgium with an implanted intrathecal pump will be enrolled in the IMPROVE study. Each participant will undergo four refill procedures: two at home and two at the hospital, in randomized order.

Being tested
Refill at the hospital, Refill at home
Keywords
Intrathecal drug delivery, intrathecal pump therapy, neuromodulation, refill, patient comfort, telemedicine, remote care, hospital to home transition

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Refill at the hospitalProcedure or surgery

    Intrathecal pump refill procedure conducted at the hospital

  • Refill at homeProcedure or surgery

    Intrathecal pump refill procedure conducted at the home of the patient

Study groups in NCT07727798
Study groupRoleWhat they receive
Refill at homeActive comparatorNot described
Receives: Procedure: Refill at home
Refill at the hospitalActive comparatorNot described
Receives: Procedure: Refill at the hospital

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Patient Comfort

    Patient comfort is evaluated with the General Comfort Questionnaire (GCQ), a self-reported instrument consisting of 48 items that reflect the physical, spiritual, environmental and social dimension. Responses are rated on a four-point Likert scale ranging from "strongly disagree" to "strongly agree". Some items are reverse scored during data processing, with higher overall scores indicating greater levels of comfort.

    Measured: At baseline and immediately after each intervention.

Secondary outcomes (15)
  1. Quality of life

    The McGill Quality of Life Questionnaire (MQOL) will measure quality of life and consists of 17 questions. Higher scores reflect a better quality of life.

    Measured: At baseline and immediately after each intervention.

  2. Health-related quality of life

    The EuroQol with five dimensions and five levels (EQ-5D-5L) will be assessed to measure health-related quality of life. Higher scores reflect a better quality of life.

    Measured: At baseline and immediately after each intervention.

  3. Pain intensity

    The Visual Analogue Scale (VAS - 100 mm) in electronic format will be used for the assessment of current pain intensity.

    Measured: At baseline and immediately after each intervention.

  4. Pain interference

    The NIH-funded Patient-Reported Outcomes Measurement Information System Pain Interference measure assesses the impact of pain on key aspects of an individual's life. It evaluates the extent to which pain disrupts engagement in social, cognitive, emotional, physical, and recreational activities.

    Measured: At baseline and immediately after each intervention.

  5. Stress

    Saliva samples will be collected to measure cortisol levels with synthetic salivettes.

    Measured: 5 minutes before the refill, immediately after the refill and 10 minutes after the refill procedure.

  6. Anxiety

    Patient anxiety will be assessed through the State Trait Anxiety Inventory (STAI). This questionnaire consists of 40 Likert-type items on a four-point scale. Higher scores are indicating higher levels of anxiety.

    Measured: At baseline and immediately after each intervention.

  7. Self-efficacy

    The General Self-Efficacy (GSE) Scale is a 10-item self-report questionnaire used to assess perceived self-efficacy.

    Measured: At baseline and immediately after each intervention.

  8. Caregiver burden

    To evaluate caregiver burden, the Zarit Burden Interview (ZBI) questionnaire will be completed. This 12-item self-report instrument assesses caregiver burden and is a shortened version of the original 22-item Zarit Burden Scale. The total score ranges from 0 to 48, with higher totals reflecting more significant caregiver burden.

    Measured: At baseline and immediately after each intervention.

  9. Patient satisfaction

    Patient satisfaction is evaluated with a seven-point Likert scale asking the patient to rate the overall level of satisfaction with the refill at home.

    Measured: Immediately after each refill procedure at home (intervention).

  10. Tele-monitoring quality

    The quality of tele-monitoring will only be evaluated after a home-filling. This will be examined using three different Likert scales to score 1) quality of audio, 2) quality of video, and 3) overall quality of the teleconsultation.

    Measured: Immediately after each refill procedure at home (intervention).

  11. Duration of refill

    The time required for the full procedure will be recorded.

    Measured: Immediately after each intervention.

  12. Safety of the refill procedure at home

    Patients will evaluate the overall safety of the procedure using a seven-point Likert scale. In addition, the researcher will assess safety on three levels: (1) overall perceived safety of the procedure using a seven-point Likert scale; (2) environmental safety, assessed through an open-ended question addressing any situations perceived as unsafe; and (3) the ability to perform the procedure in a clean and sterile manner, also evaluated via an open-ended question.

    Measured: Immediately after each refill procedure at home (intervention).

  13. Health expenditure

    Expenditures related to in hospital care will be extracted from hospital claims data. All other healthcare-related costs will be gathered through telephone interviews with patients, conducted four weeks after the first and second medication refills. During these calls, researchers will ask patients whether they have had any medical consultations, hospital admissions, adverse events, changes in medication, or incurred any additional healthcare costs.

    Measured: Four weeks after the first and second intervention.

  14. Patient preference

    After the fourth refill procedure, patients will be asked to indicate their preference (refill at home, refill in the hospital, no preference or other) for the location of their refills in the future.

    Measured: Immediately after the final study intervention

  15. Discrete choice experiment

    After the fourth refill procedure, patients will be presented with a discrete choice experiment to evaluate their preferences across several scenarios.

    Measured: Immediately after the final study intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jul 2026
  2. Study start15 Oct 2025
  3. Primary completion1 Oct 2028 (estimated)
  4. Study completion1 Oct 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
82 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07727798
Sponsor's protocol ID
25242_IMPROVE
Acronym
IMPROVE
Status last verified
Jul 2026
First submitted
29 Sep 2025
Last updated
27 Jul 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Refill at the hospital and Refill at home in people with Intrathecal Pump Refill, run by Moens Maarten at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 27 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Maarten Moens, MD PhD (+3224775514, stimulusresearchgroup@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Patient Comfort (time frame: At baseline and immediately after each intervention.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in